In the BioHarmony Drug Report Database

"Preview" Icon

Tetrabenazine

Xenazine (tetrabenazine) is a small molecule pharmaceutical. Tetrabenazine was first approved as Xenazine on 2008-08-15. It is used to treat huntington disease and hyperkinesis in the USA. The pharmaceutical is active against synaptic vesicular amine transporter. In addition, it is known to target chromaffin granule amine transporter.

 

Trade Name

 

Xenazine
 

Common Name

 

tetrabenazine
 

ChEMBL ID

 

CHEMBL117785
 

Indication

 

huntington disease, hyperkinesis
 

Drug Class

 

Image (chem structure or protein)

Tetrabenazine structure rendering